Trials / Completed
CompletedNCT02203981
TopQ Cut-off Determination Study For 3D-OCT 1 Maestro and 3D OCT-2000
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Topcon Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To determine optimal cut-off value for the TopQ cut-off on the Maestro and 3D OCT-2000.
Conditions
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-07-01
- Completion
- 2014-08-01
- First posted
- 2014-07-30
- Last updated
- 2022-06-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02203981. Inclusion in this directory is not an endorsement.